NINA DAMBROSIO: Open Payments
NPI 1952733313 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$824 in 18 payments from 8 companies in 2025. Trend: 2023 $702 · 2024 $582 · 2025 $824
Food & beverage: $724Education: $100
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 7 | $449 |
| BeOne Medicines USA, Inc. | 1 | $93 |
| Janssen Biotech, Inc. | 1 | $93 |
| Celgene Corporation | 4 | $70 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| Genentech USA, Inc. | 1 | $32 |
| GENZYME CORPORATION | 1 | $26 |
| Janssen Scientific Affairs, LLC | 1 | $23 |
Products named: JAKAFI, NIKTIMVO, BRUKINSA, RYBREVANT, BREYANZI, Columvi, REBLOZYL, MONJUVI.
Industry payments across OH — which companies pay providers there.
